Vancomycin (as HCl) 500mg/vial, 1g/vial; lyophilized pwd for IV infusion after reconstitution and dilution. The bactericidal action of vancomycin results primarily from inhibition of cell-wall ...

Purpose An original and a revised vancomycin dosing protocol for obese patients were compared with respect to attainment of target serum trough vancomycin concentrations and the occurrence of ...

The following is a summary of “Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the ...

Using vancomycin concentrations to monitor patients ... be less than 72 hours or for patients receiving oral vancomycin. Drug monitoring is more commonly recommended for patients receiving ...

Announcing a new article publication for Zoonoses journal. Methicillin resistant Staphylococcus aureus (MRSA) and Vancomycin ...

The central repository of the drug and medication centre helps to navigate to different sections. Medindia's platform provides carefully curated details on generics, brand names, side-effects ...

V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization.

DoseMe, a leader in model-informed precision dosing (MIPD), today announced that Senior Care Partners (PACE) has implemented DoseMeRx to modernize vancomycin dosing in alignment with Area Under the ...

First, Dr. Jayanta Haldar (Jawaharlal Nehru Centre for Advanced Scientific Research) will discuss the growing threat posed by drug-resistant bacteria through his work with Vancomycin, a blockbuster ...

A recent study by a team from Chiba University has demonstrated a promising approach for fighting antibiotic resistance by identifying a compound, V-161, that inhibits a sodium-pumping enzyme critical ...